Becton Dickinson

Feb 05, 2019

BD Fiscal Q1 Revenues Grow 35 Percent

The company reported growth across all three of its business segments and reaffirmed its full-year guidance.

Jan 25, 2019

In Brief This Week: Illumina, Novacyt, Lustgarten Foundation, and More

Jan 17, 2019

BD Preliminary Fiscal Q1 Revenues Up 35 Percent on Continued Bard Boost

The firm also reaffirmed its previous guidance of 10 percent growth for fiscal 2019.

Jan 15, 2019

BioMérieux, DiaSorin, GenMark, and Others Receive FDA Clearances in December

GenMark got clearance for an assay to detect fungal pathogens from blood cultures of patients with suspected bloodstream infections, and it received clearance for a bacterial assay.

Jan 10, 2019

JP Morgan Healthcare, Day 3: Quidel, Oxford Immunotec, Luminex, GenMark, Bio-Techne, and More

Among the updates provided Wednesday, Quidel's CEO noted the firm's growing presence in point-of-care markets, while PerkinElmer discussed plans for its Vanadis test.

Dec 20, 2018

Becton Dickinson Gets FDA Clearance for Enteric Viral Panel

The enteric panel detects the viral cause of infectious diarrhea symptoms including norovirus, rotavirus, adenovirus, human astrovirus, and sapovirus.

Dec 18, 2018

Ebola Point-of-Care Test Developed by BD as Proof of Concept for SERS Technology

Premium

The company developed the test with Boston University researchers as part of an effort to push its surface-enhanced Raman scattering tech for POC applications.

Nov 13, 2018

Becton Dickinson Test for Antibiotic-Resistant Bacteria Cleared by FDA

The FDA cleared BD's test for detecting carbapenemase-producing organisms, which can be used by hospitals to contain the spread of antimicrobial resistance.

Nov 06, 2018

Becton Dickinson Q4 Revenues Up 39 Percent on Bard Acquisition

The firm's full fiscal year revenues were also up, 32 percent as reported, or about 6 percent on a currency-neutral basis.

Oct 26, 2018

In Brief This Week: Quest Diagnostics, Becton Dickinson, Trinity Biotech, and More

Pages